Vedolizumab as a successful treatment of CTLA-4–associated autoimmune enterocolitis

Alexander A. Navarini(University Hospital of Zurich), Petr Hrúz(University Hospital of Basel), Christoph T. Berger(University Hospital of Basel), Tie Zheng Hou(The Royal Free Hospital), Charlotte Schwab(University of Freiburg), Annemarie Gabrysch(University of Freiburg), Rebecca Higgins(University Hospital of Zurich), Natalie Frede(University Medical Center Freiburg), Barbara-Christina Padberg Sgier(Kantonsspital Graubünden), Olle Kämpe(Uppsala University), Anne‐Valérie Burgener(University Hospital of Basel), Florian Marquardsen(University Hospital of Basel), Fabian Baldin(University Hospital of Basel), Marc B. Bigler(University Hospital of Basel), Anne Kistner(University Hospital of Basel), Annaïse Jauch(University Hospital of Basel), Olivier Bignucolo(SIB Swiss Institute of Bioinformatics), B. Meyer(University Hospital of Basel), Fabian Meienberg(University Hospital of Basel), Matthias Mehling(University Hospital of Basel), Lukas T. Jeker(University Hospital of Basel), Ingmar Heijnen(University Hospital of Basel), Thomas Daikeler(University Hospital of Basel), Jan‐Olaf Gebbers(Kantonsspital Graubünden), Bodo Grimbacher(University Medical Center Freiburg), David M. Sansom(University College London), Raphael Jeker(Kantonsspital Graubünden), Christoph Hess(University Hospital of Basel), Mike Recher(University Hospital of Basel)
Journal of Allergy and Clinical Immunology
November 28, 2016
Cited by 27Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis